Beam Therapeutics, Inc. (BEAM)

33.70 +6.15 (+22.32%) USD  |  NASDAQ  |  Jan 12, 16:00
33.69 -0.01 (-0.03%) After-Hours: 19:11
More

Beam Therapeutics Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for BEAM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Intellia Therapeutics, Inc. Upgrade
Twist Bioscience Corp. Upgrade
ANI Pharmaceuticals, Inc. Upgrade
Pacific Biosciences of California, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade